---
title: "Asieris Pharmaceuticals' director and executive Yang Mingyuan resigns for personal reasons"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259512713.md"
description: "The board of directors of Jiangsu Asieris Pharmaceutical Technology Co., Ltd. received a resignation report from Yang Mingyuan, who will resign from the positions of director, board secretary, and financial head due to personal reasons on September 30, 2025. His departure will not affect the normal operation of the board, and Chairman PANKE and Deputy General Manager ZHUANGCHENGFENGJOHN will perform the relevant duties. Yang Mingyuan holds approximately 0.13% of the shares and will comply with the reduction regulations after his departure"
datetime: "2025-09-30T11:07:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259512713.md)
  - [en](https://longbridge.com/en/news/259512713.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259512713.md)
generator: "portal-rs"
---

# Asieris Pharmaceuticals' director and executive Yang Mingyuan resigns for personal reasons

Recently, the board of directors of Jiangsu Asieris Pharmaceutical Technology Co., Ltd. received Mr. Yang Mingyuan's "Resignation Report." Due to personal reasons, Yang Mingyuan resigned from the positions of director, board secretary, and financial officer on September 30, 2025, and will no longer hold any position after his departure. His resignation does not reduce the number of board members below the legal minimum and does not affect the normal operation of the board. The resignation application takes effect upon delivery. The company will promptly appoint a new board secretary and financial officer. In the meantime, the chairman and general manager PANKE will act as the board secretary, and director and deputy general manager ZHUANGCHENGFENGJOHN will act as the financial officer. Yang Mingyuan directly and indirectly holds approximately 0.13% of the company's total share capital and will comply with relevant reduction regulations after his departure

### Related Stocks

- [688176.CN](https://longbridge.com/en/quote/688176.CN.md)

## Related News & Research

- [RemeGen Deploys Idle Funds Into Discloseable Wealth Management Products](https://longbridge.com/en/news/297779978.md)
- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [China Resources Pharma unit KPC wins registration to issue RMB 1 billion in medium-term notes](https://longbridge.com/en/news/297630970.md)
- [Gen Ilac Shares Shift to Call Auction After Circuit Breaker Halt](https://longbridge.com/en/news/297934526.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**